Kazia Therapeutics Ltd (KZIA)
$8.93+1.25%Close
SELLCRISIS · day 28
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $14M
- Beta
- 2.27
- P/E (TTM)
- -1.28
- Short % float
- 73.54%
- Days to cover
- 3.8
- SI change
- +52.6%
- 1W
- -3.67%
- 1M
- -18.89%
- vs SPY 1W
- -4.83%
- vs SPY 1M
- -21.88%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on KZIA?
- LOPJLB’s latest quantitative signal on Kazia Therapeutics Ltd ADR (KZIA) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is KZIA in?
- Kazia Therapeutics Ltd ADR (KZIA) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Kazia Therapeutics Ltd ADR (KZIA) do?
- Kazia Therapeutics Limited, together with its subsidiaries, operates as an oncology-focused biotechnology company in Israel. The company's lead development candidate is paxalisib, a small molecule, brain-penetrant inhibitor of the phosphoinositide-3-kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) pathway, which is in Phase II/III clinical trial for the treatment of glioblastoma; in Phase…